2019
DOI: 10.1186/s12879-019-4597-8
|View full text |Cite
|
Sign up to set email alerts
|

Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis

Abstract: BackgroundThe goal of this study was to further investigate the clinical effectiveness of the T-SPOT.TB test in diagnosing tuberculosis (TB), including the effects of T-SPOT.TB test on evaluating diverse TB types and locations.MethodsWe collected 20,332 specimens from patients suspected to have TB. Afterwards, we performed an integrative analysis of T-SPOT.TB results and clinical diagnoses, and evaluated the composition ratio and positive detection rate of the T-SPOT.TB test in various age groups, sample types… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 26 publications
0
19
0
Order By: Relevance
“…Notably, here the observed ESAT-6 and CFP-10 positivity rates (84.8% and 80.7%, respectively) were lower than respective rates reported previously (95.1% and 83.7%). [ 22 ] This discrepancy may reflect inconsistencies in sample sizes, inclusion criteria and study populations; our study population originated from 5 provinces and municipalities of China and included a relatively high proportion of patients with hypoproteinemia that may have had false negative IGRA results. [ 23 ] Even so, the previous study also demonstrated a higher ESAT-6 positivity rate than that obtained for CFP-10 for active tuberculosis cases, suggesting that ESAT-6 had greater antigenic dominance than CFP-10 and triggered greater IFN-γ release, in accordance with other reported studies.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, here the observed ESAT-6 and CFP-10 positivity rates (84.8% and 80.7%, respectively) were lower than respective rates reported previously (95.1% and 83.7%). [ 22 ] This discrepancy may reflect inconsistencies in sample sizes, inclusion criteria and study populations; our study population originated from 5 provinces and municipalities of China and included a relatively high proportion of patients with hypoproteinemia that may have had false negative IGRA results. [ 23 ] Even so, the previous study also demonstrated a higher ESAT-6 positivity rate than that obtained for CFP-10 for active tuberculosis cases, suggesting that ESAT-6 had greater antigenic dominance than CFP-10 and triggered greater IFN-γ release, in accordance with other reported studies.…”
Section: Discussionmentioning
confidence: 99%
“…Although WB assays are more robust than PBMCbased protocols [16], concerns about impaired test performance remain when stimulation conditions are suboptimal, e.g., in the presence of immunosuppressive therapy or after long pre-analytic delays [16,[20][21][22][23]. Furthermore, most functional T-cell assays currently applied in the clinical routine are designed to specifically detect interferon gamma (IFN-γ) [24][25][26][27] and thus require optimization for reliable analysis of the complex cytokine milieu elicited by mold antigens. Prior work suggested differential robustness of individual T-helper cell subsets, with particularly poor reliability of type 17 T-helper cell (Th17) stimulation [28] and, consequently, quantification of IL-17 [12], a cytokine regarded as a cornerstone in both protective anti-Aspergillus immunity and inflammatory immunopathology [1].…”
Section: Introductionmentioning
confidence: 99%
“…Based on the just mentioned facts, we try to benefit from ML ratio, which can help us with osteoarticular TB diagnosis since it is difficult to obtain pus or tissue for M . tb culture [ 27 ]. Besides, a bacterial culture is frequently culture-negative.…”
Section: Discussionmentioning
confidence: 99%